User profiles for Marissa Alejandria

Marissa Alejandria

University of the Philippines Manila
Verified email at up.edu.ph
Cited by 5171

Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock

MM Alejandria, MAD Lansang, LF Dans… - Cochrane Database …, 2013 - cochranelibrary.com
Background Mortality from sepsis and septic shock remains high. Results of trials on intravenous
immunoglobulins (IVIG) as adjunctive therapy for sepsis have been conflicting. This is …

Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region

…, Y Carmeli, SY Chen, S Desikan, M Alejandria… - Journal of infection, 2011 - Elsevier
Urinary tract infections (UTIs) are among the most prevalent infectious diseases in the
general population. They cause a substantial financial burden in the community and are …

[HTML][HTML] An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia

…, F Wang, M Saniel, M Alejandria… - International Journal of …, 2005 - Elsevier
BACKGROUND:: In many parts of Asia, the inaccessibility and high cost of diagnostic tests
have hampered the study of community-acquired pneumonia (CAP) caused by atypical …

Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region

TY Tan, LY Hsu, MM Alejandria, R Chaiwarith… - …, 2016 - academic.oup.com
Bloodstream infections caused by Candida species are of increasing importance and associated
with significant mortality. We performed a multi-centre prospective observational study …

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

…, M Aguilar-Guisado, F Al-Beidh, MM Alejandria… - BMC infectious …, 2021 - Springer
Background Convalescent plasma has been widely used to treat COVID-19 and is under
investigation in numerous randomized clinical trials, but results are publicly available only for a …

Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment

Q Liu, K Abba, MM Alejandria… - Cochrane Database …, 2014 - cochranelibrary.com
Background People with active tuberculosis (TB) require six months of treatment. Some
people find it difficult to complete treatment, and there are several approaches to help ensure …

Genome sequencing and analysis of an emergent SARS-CoV-2 variant characterized by multiple spike protein mutations detected from the Central Visayas Region of …

…, AA Zamora, DR Pacial, JAR Magalang, M Alejandria… - MedRxiv, 2021 - medrxiv.org
The emergence of SARS-CoV-2 variants of concern such as the B.1.1.7, B.1.351 and the P.1
have prompted calls for governments worldwide to increase their genomic biosurveillance …

Comparative effectiveness of probiotic strains for the treatment of pediatric atopic dermatitis: a systematic review and network meta‐analysis

…, MST Recto, OT Sison, MM Alejandria - Pediatric Allergy and …, 2021 - Wiley Online Library
Background The current evidence on the use of probiotics in treating atopic dermatitis is
inconclusive. This study determined the comparative effectiveness of the different types of …

Reminder systems and late patient tracers in the diagnosis and management of tuberculosis

Q Liu, K Abba, MM Alejandria… - Cochrane Database …, 2008 - cochranelibrary.com
Background Reminder systems and late patient tracers as strategies to improve patients'
adherence to tuberculosis screening, diagnosis, and treatment are used in some countries, but …

[HTML][HTML] Prevalence and risk factors for trimethoprim–sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a …

LM Gangcuangco, M Alejandria, KE Henson… - International Journal of …, 2015 - Elsevier
Background Prospective studies from developing countries that have investigated risk factors
for trimethoprim–sulfamethoxazole (TMP–SMX)-resistant Escherichia coli in women with …